Thie Quantitative and Functional Proteomics Core ofthe University of Washington Diabetes Research Center provides affiliate investigators the powerful tools of modern mass spectrometry and complex data set analysis. The goals of the Core are to: (1) Perform mass spectrometric (MS) analyses such as quantifying target analytes and obtaining spectra for structural identification of proteins. Technologies include electrospray ionization tandem mass spectrometry (ESI-MS/MS), matrix-assisted laser desorption ionization (MALDI) time-of-flight (TOF) MS, and TOF/TOF MS/MS;(2) Provide and maintain functional MS systems;(3) Develop new MS methods for structural identification or quantification of biomolecules involved in the pathogenesis of diabetes and its complications, risk factors, or treatment;(4) Provide a central facility for data storage, dissemination, and sharing;(5) Provide training in principles of MS and using MS systems, including gas chromatography (GC-MS), ESI-MS/MS, and MALDI-TOF-MS/MS analysis;(6) Reduce the cost of research by providing a centralized MS/informatics facility at a fraction of the cost of maintaining instruments and computational support in individual investigators'laboratories or of using commercial MS facilities;(7) Provide bioinformatic support for analyzing and interpreting proteomic data sets and for integrating them with Gene Ontology, protein-protein interaction databases, and pathway analysis;and (8) To integrate proteomic studies with functional studies, with the long-term aim of providing an integrated, systems biology view of diabetes and diabetes-related disease processes. By providing a centralized facility, the Core meets these goals with optimal efficiency and cost-effectiveness, avoiding the need for individuals to maintain the required instrumentation in their own laboratories or use expensive commercial mass spectrometric services. Further, by centralizing and standardizing procedures, the Quantitative and Functional Proteomics Core provides its affiliate investigators a common set of analytical tools for obtaining a unified understanding of molecular mechanisms involved in pathophysiologic processes of diabetes and its associated complications.

Public Health Relevance

The Quantitative and Functional Proteomics Core provides to affiliate investigators the powerful tools of modern mass spectrometry and complex data set analysis to assist them in their studies of diabetes and its associated complications.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK017047-37
Application #
8441177
Study Section
Special Emphasis Panel (ZDK1-GRB-S (O2))
Project Start
Project End
Budget Start
2013-03-13
Budget End
2013-11-30
Support Year
37
Fiscal Year
2013
Total Cost
$207,205
Indirect Cost
$87,721
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Banks, William A; Kovac, Andrej; Morofuji, Yoichi (2018) Neurovascular unit crosstalk: Pericytes and astrocytes modify cytokine secretion patterns of brain endothelial cells. J Cereb Blood Flow Metab 38:1104-1118
de Groot, Mary; Marrero, David; Mele, Lisa et al. (2018) Depressive Symptoms, Antidepressant Medication Use, and Inflammatory Markers in the Diabetes Prevention Program. Psychosom Med 80:167-173
Roshandel, Delnaz; Gubitosi-Klug, Rose; Bull, Shelley B et al. (2018) Meta-genome-wide association studies identify a locus on chromosome 1 and multiple variants in the MHC region for serum C-peptide in type 1 diabetes. Diabetologia 61:1098-1111
Hannon, Tamara S; Kahn, Steven E; Utzschneider, Kristina M et al. (2018) Review of methods for measuring ?-cell function: Design considerations from the Restoring Insulin Secretion (RISE) Consortium. Diabetes Obes Metab 20:14-24
Brinkley, Tina E; Anderson, Andrea; Soliman, Elsayed Z et al. (2018) Long-Term Effects of an Intensive Lifestyle Intervention on Electrocardiographic Criteria for Left Ventricular Hypertrophy: The Look AHEAD Trial. Am J Hypertens 31:541-548
Kanter, Jenny E; Kramer, Farah; Barnhart, Shelley et al. (2018) A Novel Strategy to Prevent Advanced Atherosclerosis and Lower Blood Glucose in a Mouse Model of Metabolic Syndrome. Diabetes 67:946-959
Redondo, Maria J; Geyer, Susan; Steck, Andrea K et al. (2018) TCF7L2 Genetic Variants Contribute to Phenotypic Heterogeneity of Type 1 Diabetes. Diabetes Care 41:311-317
Guillory, Bobby; Jawanmardi, Nicole; Iakova, Polina et al. (2018) Ghrelin deletion protects against age-associated hepatic steatosis by downregulating the C/EBP?-p300/DGAT1 pathway. Aging Cell 17:
RISE Consortium (2018) Impact of Insulin and Metformin Versus Metformin Alone on ?-Cell Function in Youth With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes. Diabetes Care 41:1717-1725
Osoti, Alfred; Temu, Tecla M; Kirui, Nicholas et al. (2018) Metabolic Syndrome Among Antiretroviral Therapy-Naive Versus Experienced HIV-Infected Patients Without Preexisting Cardiometabolic Disorders in Western Kenya. AIDS Patient Care STDS 32:215-222

Showing the most recent 10 out of 1296 publications